MURFU — Conduit Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $989.08m
- $989.55m
Annual cashflow statement for Conduit Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -0.004 | 0.399 |
| Non-Cash Items | 0.004 | -1.98 |
| Other Non-Cash Items | ||
| Changes in Working Capital | -0.006 | 0.266 |
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accrued Expenses | ||
| Change in Taxes Payable | ||
| Cash from Operating Activities | -0.006 | -1.31 |
| Other Investing Cash Flow Items | — | -135 |
| Purchase of Investments | ||
| Cash from Investing Activities | — | -135 |
| Financing Cash Flow Items | -0.045 | -3.11 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 0.055 | 137 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0.049 | 0.297 |